Navigation Links
Pharmaceutical Partnership Deal Terminations
Date:9/7/2011

r, Open-Label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed Flutiform HFA pMDI Study SKY2028-3-005 107

Table 73: Top Partnership Deal Terminations, Clinical Trial Details, Merck Vaccine Study in Healthy Adults, 2006 111

Table 74: Top Partnership Deal Terminations, Clinical Trial Details, Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant, 2006-2007 112

Table 75: Top Partnership Deal Terminations, Clinical Trial Details, Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery, 2007-2014 112

Table 76: Top Partnership Deal Terminations, Clinical Trial Details, V710 Clinical Study in Healthy Male Japanese Subjects, 2008 113

Table 77: Top Partnership Deal Terminations, Clinical Trial Details, A Study to Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis, 2008-2010 113

Table 78: Top Partnership Deal Terminations, Merck-Intercell Licensing Agreement, Deal Value ($m), 2004 114

1.2 List of Figures

Figure 1: Top Partnership Deal Terminations, Licensing Strategies in Large Pharmaceutical Companies, Pharmaceutical Licensing Life Cycle, 2011 10

Figure 2: Top Partnership Deal Terminations, Reasons for Deal Terminations, 2010-2011 12

Figure 3: Top Partnership Deal Terminations, Therapeutic Areas, 2010-2011 13

Figure 4: Top Partnership Deal Terminations, Comparative Analysis of Deal Values of the Top Terminated Deals, 2010-2011 14

Figure 5: Top Partnership Deal Terminations, GlaxoSmithKline Terminates Licensing Agreement with Actelion for Almorexant, 2011 16

Figure 6: Top Partnership Deal Terminations, GlaxoSmithKline Terminates Co-Development Agreement with Targacept for Development of Neuronal Nicotinic Receptor Therapeutics, 2011 20

Figure 7: Top Partnersh
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
2. Webcast Alert: Isis Pharmaceuticals Hosts Dr. John Kastelein to Review Mipomersen Long-term Data Recently Presented at ESC Congress 2011
3. Omthera Pharmaceuticals, Inc. to Present at the Rodman and Renshaw 13th Annual Healthcare Conference
4. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
5. Access Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference on Monday, September 12th in New York City
6. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12
7. Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
8. Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
9. Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity
10. Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
11. Pacira Pharmaceuticals, Inc. Expands EXPAREL™ Commercial Team Infrastructure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... KIRKLAND, Wash. , Aug. 19, 2014 ... solutions, will be exhibiting at the 2014 NPPA Summer ... The company will be showcasing its 340B software products ... leader in 340B splitting solutions, supplying over 400 customers ... a range of 340B solutions including its latest solution, ...
(Date:8/19/2014)... YORK , Aug. 19, 2014 /PRNewswire-iReach/ -- ChemImage ... will present a scientific poster describing an innovative diagnostic ... SPEC 2014: Shedding New Light on Disease (SPEC) conference ... Dr. Treado,s poster entitled, "Development of in vitro ... Imaging" will be discussed during the conference poster session ...
(Date:8/19/2014)... , Aug. 19, 2014  Tokyo-based Atonarp Inc. ... funding round led by Walden Riverwood Ventures with ... development of Atonarp,s Smart Spectrometer technology platform, which ... company has targeted the oil & gas and ... "We are excited to partner with Atonarp in ...
Breaking Medicine Technology:Talyst Exhibits at the NPPA Summer Conference 2ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2
... China Botanic Pharmaceutical Inc. (AMEX: CBP ) ... distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ... the Company,s new Chief Financial Officer ("CFO") on December ... over 10 years with key positions in finance, audit, ...
... Calif. and LUXEMBOURG, Dec. 16, 2010 WaferGen Biosystems, ... leading developer of state-of-the-art genomic analysis systems, and the ... to establish a strategic relationship that will expand the ... Europe and advance personalized medicine.   The ...
Cached Medicine Technology:China Botanic Appoints David Dong as New Chief Financial Officer 2China Botanic Appoints David Dong as New Chief Financial Officer 3WaferGen and Integrated BioBank of Luxembourg (IBBL) Sign Strategic Agreement for Molecular Diagnostic Research Collaboration and Purchase of SmartChip System 2WaferGen and Integrated BioBank of Luxembourg (IBBL) Sign Strategic Agreement for Molecular Diagnostic Research Collaboration and Purchase of SmartChip System 3WaferGen and Integrated BioBank of Luxembourg (IBBL) Sign Strategic Agreement for Molecular Diagnostic Research Collaboration and Purchase of SmartChip System 4WaferGen and Integrated BioBank of Luxembourg (IBBL) Sign Strategic Agreement for Molecular Diagnostic Research Collaboration and Purchase of SmartChip System 5
(Date:8/20/2014)... August is Children’s Eye Health and ... about eye health and safety for their children and ... condition that must be checked for, according to Sharon ... Water radio show, is pediatric dry eye. With computer ... eye is becoming a very real concern to ophthalmologists. ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Biosimilars, ... that are approved through an abbreviated process, could ... issue of Atlantic Information Services, Inc.’s (AIS) Specialty ... this segment, including the Food and Drug Administration’s ... first step towards approval. , Drugmaker Sandoz said ...
(Date:8/20/2014)... August 20, 2014 Ticketability.com ... public at fair prices. The well-known medium has been ... is now touring in 19 cities, with tickets becoming ... television personality will visit are Albany, Baltimore, Trenton, Erie, ... Albuquerque, Beverly Hills and San Diego. The medium’s fans ...
(Date:8/20/2014)... often have difficulty falling asleep and staying asleep, and ... individuals with Alzheimer,s disease, this common and troubling symptom ... to nighttime confusion and wandering. , Now, a study ... (BIDMC) and the University of Toronto/Sunnybrook Health Sciences Center ... Reported online today in the journal Brain , ...
(Date:8/20/2014)... At this moment, Ebola is causing horrific, ... the root cause of the virus and other problems Africans ... nonprofit organization Books For Africa to provide copies of his ... Live the Life of Their Dreams, to those who could ... with the tools they need to make the leap to ...
Breaking Medicine News(10 mins):Health News:August is Children’s Eye Health Month, Exams Must Check for Pediatric Dry Eye 2Health News:August is Children’s Eye Health Month, Exams Must Check for Pediatric Dry Eye 3Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 2Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 3Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2Health News:Research helps explain why elderly have trouble sleeping 2Health News:Research helps explain why elderly have trouble sleeping 3Health News:Ebola, Poverty, and a Partnership for Africa—How Everyone Can Help 2Health News:Ebola, Poverty, and a Partnership for Africa—How Everyone Can Help 3
... heart attacks, strokes among those without established heart ... An analysis of studies supports a growing belief ... be expanded to include healthy people without established ... 10 trials involving more than 70,000 participants found ...
... Services to Focus on the Delivery of Early Stage Services -, ... July 1 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: ... global life sciences markets, today announced that it has completed the ... Under the terms of the agreement, INC Research, a leading global ...
... new treatments eliminate risks of traditional procedures , , ROSEMONT, ... respond successfully to initial treatment may have a second chance at ... area, according to a study published in the July 2009 issue ... Academy of Orthopaedic Surgeons (JAAOS). ...
... Netherlands: Survivors of childhood cancer run particular risks ... 25th annual conference of the European Society of ... July). Dr. Sharon Lie Fong, of the Department ... Centre, Rotterdam, The Netherlands, said that, although such ...
... , AstraZeneca Patent Shown to be Invalid Based on New ... , , NEW YORK, July 1 Article ... validity of AstraZeneca,s Crestor U.S. drug patent, in closing out ... premier validity evidence which can show the Crestor patent to ...
... ... Center Leverages Fusionfx Solution Suite to Improve Patient Experience , ... Scottsdale, AZ (Vocus) June ... a nationally recognized non-profit provider of integrated health services, has chosen the Fusionfx ...
Cached Medicine News:Health News:Study Supports Wider Use of Statins 2Health News:Study Supports Wider Use of Statins 3Health News:MDS Inc. Completes Divestiture of MDS Pharma Services Phase II-IV Operations 2Health News:Emerging Techniques Put a New Twist on Ankle Repair 2Health News:Emerging Techniques Put a New Twist on Ankle Repair 3Health News:Cancer survivors at greater risk of birth complications; special monitoring needed 2Health News:Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community 2Health News:Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community 3Health News:Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community 4Health News:Virginia Mason Signs with Carefx to Implement Fusionfx Solution Suite 2Health News:Virginia Mason Signs with Carefx to Implement Fusionfx Solution Suite 3
Inquire...
Inquire...
... Optimal for Subcellular Fractionation, ... x g (30,000 rpm) with ... from 0.25 up to 85 ... 2° C to 40° C ...
... Fractionation, Proteins and Viruses • ... with fixed-angle rotor • Spin ... 85 mL • Operating temperature ... C • Rotors certified by ...
Medicine Products: